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The so-called functional somatic syndromes comprise a group of disorders that are primarily symp-
tom-based, multisystemic in presentation and probably involve alterations in mind-brain-body inter-
actions. The emerging neurobiological models of allostasis/allostatic load and of the emotional motor
system show striking similarities with concepts used by Traditional Chinese Medicine (TCM) to
understand the functional somatic disorders and their underlying pathogenesis. These models incor-
porate a macroscopic perspective, accounting for the toll of acute and chronic traumas, physical and
emotional stressors and the complex interactions between the mind, brain and body. The convergence
of these biomedical models with the ancient paradigm of TCM may provide a new insight into scien-
tifically verifiable diagnostic and therapeutic approaches for these common disorders.
Keywords: functional somatic syndromes – allostasis – emotional motor system – stress – mind-brain-
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Introduction
The functional somatic syndromes comprise a large group of
symptom-based disorders that are poorly understood and
inadequately treated. Nevertheless, they have a major impact
on the health-related quality of life (HRQoL) of affected
patients. These disorders include (but are not limited to)
fibromyalgia, myofascial pain syndromes, chronic headaches,
temporomandibular disorder, chronic fatigue syndrome, irri-
table bowel syndrome (IBS), interstitial cystitis and pelvic
pain syndromes. Reliable and specific biological disease
markers to assist in diagnosis have not yet been identified (1–
4). As a result, each of these syndromes is currently defined
by separate symptom-based diagnostic criteria (4–9). Al-
though certain syndromes have presentations with symptoms
predominant in one organ system (e.g., bowel symptoms in
IBS), patients almost universally present with significant
symptomatology across multiple organ systems (2,4,6,10).
Another feature that is common to these disorders is a strong
history of physical and/or emotional stressors and concurrent
mood disturbances (1,7,11). Since few conventional medica-
tions have shown satisfactory results, several patients have
turned to complementary and alternative modalities for relief
Two emerging biomedical models with the potential to fur-
ther our understanding of the functional somatic syndromes
are allostasis/allostatic load and the emotional motor system
(EMS) (14–18). These models explore the complicated inter-
actions of physical and emotional stressors in the genesis of
symptoms and diseases. Similarly, in the ancient paradigm of
Traditional Chinese Medicine (TCM), physical and emo-
tional states are inextricably linked with maintaining health
or precipitating illness (19–21). In this paper, we discuss how
the convergence of these biomedical models with the ancient
healing tradition of TCM may provide novel perspectives in
understanding these challenging and elusive disorders.
The Challenge of Functional Somatic Syndromes
Functional somatic syndromes pose a challenge to clinicians
for several reasons.
Functional Versus Organic
Current biomedical thinking emphasizes identification of
specific diseases to explain symptoms over analysis of general
symptom patterns (4–6). Diseases are usually defined by
specific pathophysiological processes using generally agreed
upon biological markers. In the case of functional somatic
syndromes, the etiology and pathophysiology are yet to be
identified, and no reliable diagnostic markers are currently
available. Hence, diagnosis of these syndromes is made on
the basis of symptom-based criteria. The lack of detectable
36 Biomedical models and Traditional Chinese Medicinephysiological or anatomical abnormalities often diminishes
the relevance, or even questions, the actual existence of such
symptoms and syndromes (22–27). This implication is seen in
the general designation of these disorders as ‘functional’ as
opposed to ‘organic’ (4–6,10).
Multisystemic Manifestations
Although affected patients frequently present with predomi-
nant symptom features pertaining to one organ system at the
time of consultation, the majority has multisystemic symp-
tomatology when assessed comprehensively. The presence of
multiple symptoms involving pain, discomfort and decrease
of vital functions is believed to result in a significant impair-
ment of HRQoL of affected patients (28,29). Symptom clus-
ters, which defy a unifying disease process defined at the
organ, cellular, genetic and molecular levels, are challenging
to understand with our current state of medical knowledge
and technology (5,6). This may explain why several different
subspecialties apply their own subspecialty-biased conceptu-
alization and symptom criteria to the same group of disor-
ders. This process creates the false appearance of multiple,
separate diseases that require different, peripherally targeted
treatments, even though the relevant peripheral targets
remain elusive.
Emerging approaches that incorporate a broader ‘holistic’
view of these disorders may be more appropriate. Specifi-
cally, the authors of this review and other researchers have
proposed that the multiple, and seemingly disparate symp-
toms of affected patients represent more general patterns of
dysregulation of mind-brain-body interactions (2,10,30–32).
This concept is supported by the failure of medications aimed
at specific peripheral targets (e.g., normalization of altered
bowel movements in IBS) to substantially improve overall
symptoms and HRQoL measures. In contrast, treatment of
these disorders with agents such as tricyclic anti-depressants
and other centrally-acting medications has achieved greater
success (3,29,33–35).
Stress Sensitivity
Another challenge to clinicians is that several functional dis-
orders are strongly associated with a history of certain types
of stress, and frequently overlap with disorders of mood and
affect. This association, combined with the lack of detectable
abnormal diagnostic tests, has often led clinicians to label
these symptoms as ‘psychosomatic,’ ‘somatoform’ and
‘hypochondriacal’ (3,4,7,31). Modern medicine has only
recently begun to systematically explore the association
between emotional and cognitive states and physiological
changes. Current research, including observational and epi-
demiological studies, have shown associations between cer-
tain types of stressors (in particular, sustained, severe and
uncontrollable stressors) and adverse clinical outcomes in
diseases involving almost every organ system (14,15,18). The
specific physiological mechanisms by which mind-brain-body
interactions actively maintain health, and the manner in
which a dysregulation of these interactions can result in
chronic disease are rapidly being identified (14). The authors
believe that a better characterization of the connections
between stress, mind and body will probably play a crucial
role not only in a better understanding of health and disease,
but in shifting the focus from arbitrarily defined symptom cri-
teria to a physiologically-based understanding of functional
somatic syndromes.
Allostasis/Allostatic Load and the EMS as Biomedical 
Models to Explain Functional Somatic Syndromes
Two closely related biomedical models that show promise in
providing a scientific, biomedical basis for understanding the
multisystemic presentations of functional somatic syndromes
are allostasis/allostatic load (36) and the EMS (16).
Together, these two models provide a useful framework to
explain multiple symptom presentations, central dysregula-
tions and the association of symptoms with psychosocial
factors.
Allostasis and Allostatic Load
Allostasis refers to the process by which our bodies maintain
homeostasis in response to environmental change or stres-
sors. Key homeostatic mechanisms through which allostasis
works include ascending monoaminergic systems (including
the serotonergic, noradrenergic and cholinergic pathways),
the hypothalamic-pituitary-adrenal (HPA) axis, endogenous
pain modulation networks and autonomic and skeletomotor
pathways. Allostatic responses to limited or acute changes in
the environment are generally adaptive in nature. However,
persistent stressors and/or chronic illness result in maladap-
tive responses reflected by sustained hyperactivity or ineffec-
tiveness of allostatic mediators. This breakdown of the
system and the consequent inability of the organism to main-
tain homeostasis ultimately results in a reduction of HRQoL
and well-being of affected individuals (30). The damage that
occurs within the organism when the allostatic response
functions improperly is referred to as the allostatic load.
This allostatic load can result in several common medical
syndromes, ranging from ischemic heart disease and the
metabolic syndrome to symptom complexes referred to as
functional somatic syndromes (14,15).
EMS
The EMS is central to regulating mind-brain-body interac-
tions (Fig. 1). It explains the manner in which perturbations
of the organism’s homeostasis initiate stereotypic events in
central regulating pathways, resulting in distinct, emotion-
specific patterns of changes in the body (body maps). These
bodily changes are highly adaptive to the organism’s response
to the environment, but are not necessarily associated with
conscious perception of distinct emotional feelings (37). Neu-
roanatomically, the EMS refers to a set of parallel, efferent
pathways that regulate the somatic, pain modulatory, auto-
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and external perturbations. The mind and body outputs of
these efferent pathways, in turn, serve as feedback inputs into
EMS circuits, explaining how the mind and body interactions
are interlinked and mutually dependent. Vulnerability factors
for altered responsiveness of subsystems of the EMS include
genetic factors, early life experiences and severe life threaten-
ing stressors (Fig. 2) (16,17,30).
The TCM Perspective on Functional Somatic 
Syndromes
In TCM, health is defined as a state of optimal balance
between opposing processes in the body, referred to as yin
and yang. Individuals have an underlying genetically deter-
mined constitution, referred to as jing, which reflects the
innate ability of the individual to maintain balance and
health. This constitution is either strengthened or weakened
throughout an individual′s lifetime, depending on life style,
Figure 1. The Emotional Motor System. The EMS refers to a parallel set of outputs from limbic and paralimbic circuits, which generate distinct patterns of
body functions (‘body map’) associated with specific emotions (fear, anger, joy, etc). These outputs occur in the form of autonomic nervous system responses,
sensory modulations and HPA axis responses. Feedback from the body to the EMS in the form of afferent nerve signals and neuroendocrine signals modify
EMS responses. Ascending outputs to cortical regions of the brain generate patterns of vigilance, arousal and attention. The conscious perception of emotional
feelings may or may not be associated with activities of the EMS (modified from Mayer et al. 2001) (44).
Figure 2. Interaction of genetic factors with early life events to generate vulnerabilities for stress-sensitive disorders. Genetic predisposition (presumably multi-
genetic traits) interacts with prenatal and early life stressors to program the stress responsiveness (or resilience towards stress) of the adult organism. This
enhanced stress responsiveness pertains to both psychological and physical stressors. Perpetuating factors that play a role in the chronicity of symptoms
include symptom-related fears and anxiety (modified from Mayer and Collins, 2002) (45).
38 Biomedical models and Traditional Chinese Medicinephysical stressors, environmental exposure and emotional
stressors. In contrast to conventional medicine, TCM empha-
sizes that emotional well-being and physical health are
inextricably linked. In fact, TCM has elaborate theories
on the differential association of distinct emotional patterns
with different bodily processes (19–21,35).
When exposed to a stressor, the system attempts to main-
tain balance by engaging a series of responses through medi-
ators described in ancient medical literature such as qi, blood
and essence, to name a few. Imbalances result when these
mechanisms fail to maintain a balance between yin processes
and yang processes. This underlying imbalance systemically
disrupts physiological processes, which accounts for a
constellation of symptom manifestations (19–21,35). Initial
responses to an acute stressor via these physiological media-
tors are generally adaptive in nature. However, given sus-
tained stressors or an acute, severe stressor in a weakened
system, these adaptive processes may be severely compro-
mised or permanently disabled. This results in an exhaustion
of homeostatic reserves manifesting as persistent, unrespon-
sive and chronic symptoms commonly encountered in func-
tional somatic syndromes.
From the TCM perspective, symptoms represent the clini-
cal manifestation of a broader underlying pattern of dys-
regulation. As a result, a single presenting symptom is rarely
studied in isolation. Instead, the presenting symptom is
assessed in the context of concurrent symptoms, as well as
symptom modifiers. TCM practitioners use this macroscopic
symptom assessment with other clinical observations such as
tongue and pulse diagnosis to identify the most probable
pattern of dysregulation. The pattern diagnosis is then used
to formulate a treatment plan using acupuncture and herbal
medicine (19–21,35). A natural consequence of this clinical
approach is that several patients presenting with the same
chief complaint and Western disease diagnosis (e.g., consti-
pation-predominant IBS, interstitial cystitis, heartburn) may
each receive a different TCM pattern diagnosis. Patients with
the same Western diagnosis may receive different treatments
with acupuncture and herbs. The awareness that different
subgroups of patients present with the same chief complaint
reflects our increasing understanding of the existence of dif-
ferent subgroups of patients within each functional somatic
syndrome, which may show differential responses to different
therapeutic interventions.
The Convergence of Biomedical Models and 
TCM
Although their derivations were in different millennia, the
modern biomedical models of allostasis/allostatic load and
the EMS share striking similarities with the ancient paradigm
of TCM. Their convergence conceptualizes a possible expla-
nation for the genesis of many of the functional somatic
syndromes that currently confound and defy conventional
approaches.
Unlike conventional medicine’s emphasis on physical stres-
sors, the allostatic load model places equal emphasis on the
significance of emotional and mental stressors as having seri-
ous detrimental effects on the body. The TCM observation
that psychological stressors lead to physical symptoms and
vice versa can be modernized through allostasis/allostatic
load and the EMS. They not only describe the physiological
output resulting from emotional stressors but also describe a
modifiable gain system affected by physiological input from
the periphery.
Both stress the fundamental importance of homeostasis in
the body. In fact, in modern Western and TCM paradigms,
the basic goal in maintaining health is preservation of bal-
ance, described in each paradigm as homeostasis or balance
of yin and yang, respectively. In the process of allostasis, the
organism invokes physiological changes mediated by broadly
acting regulatory systems in response to a stressor that
threatens (or is perceived as threatening) homeostasis. The
TCM theory of yin and yang describes this same phenome-
non. However, instead of referring to the mediators of
homeostatic regulation as glucocorticoids, serotonin or
catecholamines, TCM mediators are described by terminol-
ogy such as qi, blood and essence.
Both models allow for a period during which an individual
is able to accommodate for stressors. The breakdown of
homeostasis involves several factors. One key factor is an
individual’s underlying constitution. Allostasis describes
inherited genetic traits and early life events as conferring
stress resilience to an individual. In TCM, this is referred to as
a person’s jing (19–21). These references to a person’s innate
reserve explain the common clinical experience that indi-
viduals differ in stress adaptabilities and susceptibilities.
Regarding functional somatic syndromes, this underlying
vulnerability accounts for individual tendencies to develop
adverse outcomes from stressors that most individuals are
otherwise able to tolerate.
In conjunction with an individual’s underlying constitution,
the breakdown of homeostasis results from chronic, sus-
tained stress, with or without punctuation by a severe, acute
stressor. Patients with functional somatic syndromes often
convey a long history of repeated life stressors during which
most symptoms are self-limiting or relatively quiescent. This
may represent initial adaptive responses of homeostatic
mechanisms. However, either after an acutely stressful event
or after several years of stressors, symptoms seem to suddenly
arise and persist thereafter. This is consistent with both
models in which, after a critical degree of stress, compensa-
tory mechanisms are overloaded and thereafter fail to func-
tion optimally, ultimately leading to symptoms. In this way,
the concept of allostatic load can be considered similar to the
patterns of dysregulation in TCM.
Rather than affecting only one peripheral target, both
ancient and modern models purport that pathological stres-
sors systemically disturb the mind-brain-body continuum. (A
pathological stressor, in this context, refers to a perturbation
that is severe or sustained enough to result in allostatic load.)
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ing pattern of dysregulation which manifest with multi-
systemic symptomatology. Within the model of allostatic
load, stressors affect broadly acting regulating mechanisms,
resulting in a similar multisystemic presentation. This con-
ceptualization better explains why the majority of patients
with functional somatic syndromes, regardless of the specific
disorder for which they seek medical care, will present
symptoms from multiple systems. Further, many present
complex symptoms such as fatigue, lethargy, low resilience,
sleep disturbance and mood disturbance, which are difficult
to explain by a specific organ dysfunction. These systemic
symptoms are easily explained by a complex interplay of
alterations in ascending monoaminergic systems (e.g., deple-
tion of serotoninergic mechanisms and upregulation of
noradrenergic systems), tonic and phasic alterations of
autonomic nervous system activity (e.g., low cardiovagal
tone, increased sympathetic nervous system reactivity),
alterations in HPA axis tone and responsiveness and tonic
and phasic pain modulation systems (38–41).
Limitations
As intriguing as the comparison between the ancient TCM
paradigm and the emerging modern neurobiological models
may be, they are simply comparisons at this point. The simi-
larities are most striking in the TCM pattern diagnosis, where
specific somatic patterns are associated with specific altera-
tions of emotions. Other aspects of the TCM paradigm, such
as the concept of qi and the meridians, have not been
addressed in our discussion and may be more difficult to
address from a Western scientific perspective. Finally, the
apparent similarities between TCM pattern classification and
distinct mind-brain-body states will need to be verified in
future hypothesis-driven mechanistic studies.
Future Directions
The correlations between TCM, allostasis/allostatic load and
EMS models offer exciting opportunities to scientifically test
novel theories on the pathogenesis of the functional somatic
syndromes and to investigate biomedical explanations under-
lying ancient TCM terms and concepts. For example, in the
case of IBS, current diagnosis under the Rome criteria
focuses solely on bowel symptoms (42). However, in clinical
practice most IBS patients present significant extra-intestinal
symptomatology. In fact, clinical evidence suggests that
normalization of bowel habits alone by anti-diarrheals or
pro-motility drugs is unlikely to produce large improvements
in global endpoints when compared to placebo (33,43).
Further, the present group has demonstrated that both
mental and physical component scores for HRQoL in IBS are
primarily determined by extra-intestinal symptoms rather
than conventionally-elicited bowel symptoms (29). Rather
than conventionally subgrouping IBS patients on the basis of
bowel habits alone (e.g., constipation- versus diarrhea-pre-
dominant), TCM broadly subgroups patients into deficiency
(i.e., yin) or excess (i.e., yang) types based on extra-intestinal
symptoms such as fatigue versus hyperactivity or weak stress
resilience versus stress-induced overstimulation. The present
group has hypothesized that this TCM approach potentially
offers novel and scientifically testable subgroups of IBS rep-
resenting differential dysfunction (i.e., hypofunctioning in yin
types and hyper-responsiveness in yang types) of allostasis
and EMS output profiles. Specifically, we have begun pre-
liminary physiological studies comparing basal and stress-
induced autonomic differences in IBS patients to determine if
our hypothesis is supported. We believe integrative East–
West approaches such as this represent a sound first step
towards scientifically validating the ancient theories of TCM
while throwing light on central physiological derangements
underlying the functional somatic syndromes.
Conclusions
The functional somatic syndromes pose a challenge to mod-
ern medicine, because they are primarily symptom-based,
multisystemic in presentation and probably involve complex
mind-brain-body interactions. They represent a group of dis-
orders that cannot be easily classified under the conventional
biomedical model which is primarily focused on specific dis-
eases defined by structural, and often microscopic, single-
variable parameters confined to a particular organ. The
challenge at hand is to find novel approaches that incorpo-
rate a macroscopic perspective, taking into account the toll of
acute and chronic traumas, physical and emotional stressors
and the complex interaction between the mind, brain and
body.
The emerging biomedical models of allostasis/allostatic
load and the EMS show striking similarities to TCM in con-
ceptualization of the functional somatic disorders and their
underlying pathogenesis. The convergence of these models
may provide new insight into scientifically verifiable diagnos-
tic and therapeutic approaches for these common disorders.
From a broader perspective, further exploration of the links
between these models will undoubtedly bridge the gap in our
understanding of the relationships between mind and body,
ancient wisdom and modern science, and Eastern and West-
ern approaches to health and disease.
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